+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Stents: Technologies and Global Markets 2022-2027

  • PDF Icon

    Report

  • 152 Pages
  • June 2022
  • Region: Global
  • BCC Research
  • ID: 5603759
The global market for stents is estimated to increase from $7.8 billion in 2022 to $9.7 billion by 2027, at a compound annual growth rate (CAGR) of 4.3% during the forecast period of 2022 through 2027.



The global market for stents by vascular therapeutic application is estimated to increase from $7.1 billion in 2022 to $8.7 billion by 2027, at a CAGR of 4.2% during the forecast period of 2022 through 2027.

The global market for stents by nonvascular therapeutic application is estimated to increase from $760.4 million in 2022 to $970.5 million by 2027, at a CAGR of 5.0% during the forecast period of 2022 through 2027.


Report Scope

This report aims to provide a comprehensive study of the global market for stents, both in terms of quantitative and qualitative data, to help businesses develop growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding stent devices.

An in-depth analysis of the global stents market includes historical data and market projections on sales by product type, application, and region. It describes different types of stents (bare metal, drug-eluting, bioabsorbable, and others) and their current and historical market revenues. This report also categorizes the global stents market based on application (vascular and nonvascular). The vascular stents market is divided into coronary and peripheral vascular. Peripheral vascular stents are segmented into peripheral lower extremity, carotid and intracranial and renal. The peripheral lower extremity is further segmented as iliac and other lower extremities. The nonvascular stent market is divided into ureteral, gastrointestinal (colorectal, esophageal, duodenal), bile duct/pancreatic and tracheobronchial/pulmonary.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market shares. The report also discusses technological trends and new product developments.

The scope of this report does not include endovascular graft/stent grafts indicated for aortic and other types of aneurysm treatment and for use in the treatment of free perforations or ruptures.

The Report Includes

  • 33 data tables and 33 additional tables
  • An up-to-date review of the global markets for stents and associated medical device technologies
  • Analyses of the global market trends, with revenue sales data from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Evaluation and forecast of the global stents market size, forecasted growth trends, and corresponding market share analysis by product type, therapeutic application, and geographic region
  • Identification of promising new products (stents) and technologies that are still in development and assess the probability of their successful commercialization over the next few years
  • In-depth information (facts and figures) concerning market drivers, market deterrents and other demographic and economic factors influencing the progress of the global stents marketplace
  • Discussion of the regulatory structure for medical stents, pricing and reimbursement structure, marketed and pipeline products, and major developments influencing the medical devices industry
  • Insight into recent industry structure, the competitive landscape for major types of stents manufacturers, ongoing research activities and their clinical trials
  • Key merger and acquisition deals, product approvals/launches, agreements, collaborations, and other strategic alliances within the MedTech industry
  • Descriptive company profiles of the leading global players, including Abbott Laboratories, B. Braun Melsungen AG, BD, Biotronik SE, Boston Scientific Corp., Cook Medical LLC, Medtronic plc and Terumo Corp.
Frequently Asked Questions about the Global Stents Market

What is the estimated value of the Global Stents Market?

The Global Stents Market was estimated to be valued at $7.8 Billion in 2022.

What is the growth rate of the Global Stents Market?

The growth rate of the Global Stents Market is 4.3%, with an estimated value of $9.7 Billion by 2027.

What is the forecasted size of the Global Stents Market?

The Global Stents Market is estimated to be worth $9.7 Billion by 2027.

Who are the key companies in the Global Stents Market?

Key companies in the Global Stents Market include Abbott Laboratories, B. Braun Melsungen Ag, Becton, Dickinson and Co., Biosensors International, Biotronik Se & Co. Kg, Boston Scientific Corp., Cook Medical Llc, Cordis Corp. and Medtronic Plc.

Table of Contents

Chapter 1 Introduction
  • Study Goals and Objectives
  • Scope of Report
  • Methodology and Information Sources
  • What's New in This Update?
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
  • Stent Overview
  • Balloon-Expanded (BE) Stents
  • Self-Expanding Stents
  • Angioplasty
  • Coronary Artery Disease (CAD)
  • Symptoms of CAD
  • Causes of CAD
  • Risk factors for CAD
  • Treatment for CAD
  • Peripheral Artery Disease (PAD)
  • Symptoms of PAD
  • Treatment for PAD
Chapter 4 Regulatory Structure
  • Medical Device Regulations for Selected Countries
  • United States
  • Canada
  • European Union
  • Japan
  • China
Chapter 5 Market Breakdown by Application
  • Overview
  • Vascular
  • Coronary
  • Peripheral Vascular
  • Nonvascular
  • Ureteral
  • Gastrointestinal
  • Biliary and Pancreatic
  • Tracheobronchial/Pulmonary
  • Global Market for Stents, by Therapeutic Application
  • Global Market for Vascular Stents, by Therapeutic Application
  • Global Market for Coronary Stents
  • Global Market for Peripheral Vascular Stents, by Therapeutic Application
  • Global Market for Nonvascular Stents, by Therapeutic Application
  • Ureteral Stents
  • Gastrointestinal Stents
  • Biliary and Pancreatic Stents
  • Tracheobronchial/Pulmonary Stents
Chapter 6 Market Breakdown by Product Type
  • Overview
  • Stent Material
  • Bare-Metal Stent (BMS)
  • Drug-Eluting Stents (DES)
  • Drugs Used in DES
  • Polymer-Based DES
  • Polymer-Free DES (PF-DES)
  • Biodegradable/Bioabsorbable Stents (BDS)
  • Technological Advantages of BDS
  • Technological Disadvantages of BDS
  • Other Stents
  • Covered Stents
  • Plastic, Hybrid Material, and Silicone Stents
  • Global Market for Stents, by Stent Type
  • Market Analysis
  • Market Revenue
  • Global Market for Vascular Stents, by Stent Type
  • Market Analysis
  • Market Revenue
  • Global Market for Coronary Stents, by Stent Type
  • Global Market for Peripheral Vascular Stents, by Stent Type
  • Global Market for Nonvascular Stents, by Stent Type
  • Market Analysis
  • Market Revenue
Chapter 7 Market Breakdown by Region
  • Global Market for Stents, by Region
  • North America
  • North American Market for Vascular Stents, by Therapeutic Application
  • North American Market for Nonvascular Stents, by Therapeutic Application
  • Europe
  • European Market for Vascular Stents, by Therapeutic Application
  • European Market for Nonvascular Stents, by Therapeutic Application
  • Asia-Pacific
  • Asia-Pacific Market for Vascular Stents, by Therapeutic Application
  • Asia-Pacific Market for Nonvascular Stents, by Therapeutic Application
  • Rest of World
  • RoW Market for Vascular Stents, by Therapeutic Application
  • RoW Market for Nonvascular Stents, by Therapeutic Application
Chapter 8 Market Dynamics
  • Market Drivers
  • Favorable Global Demographics and Aging Population
  • Greater Incidence of Non-Communicable/Chronic Diseases
  • Continuous Product and Technology Developments
  • Other Drivers
  • Market Restraints
  • Alternative Technologies
  • Decline in Average Selling Prices
  • Stringent Regulatory Environment
  • Coverage and Reimbursement Issues
  • Other Restraints
  • Market Trends
  • Impact of COVID-19
Chapter 9 Competitive Landscape
  • Overview
  • Key Stent Manufacturers' Offerings, by Application Types
  • Global Company Ranking
  • Coronary Stents
  • Peripheral Vascular Stents
  • Nonvascular Stents
  • Recent Industry Activities
Chapter 10 Company Profiles
  • Abbott Laboratories
  • B. Braun Melsungen Ag
  • Becton, Dickinson And Co.
  • Biosensors International
  • Biotronik Se & Co. Kg
  • Boston Scientific Corp.
  • Cook Medical Llc
  • Cordis Corp.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic Plc
  • Terumo Corp.
  • W. L. Gore & Associates, Inc.
Chapter 11 Appendix: Acronyms
List of Tables
Summary Table A: Global Market for Stents, by Therapeutic Application Type, Through 2027
Summary Table B: Global Market for Vascular Stents, by Therapeutic Application Type, Through 2027
Table 1: Stents Classification, by FDA Approval Pathway
Table 2: Pharmaceutical Affairs Law and Japanese Medical Devices Nomenclature and Related Codes
Table 3: Global Market for Stents, by Therapeutic Application Type, Through 2027
Table 4: Global Market for Vascular Stents, by Therapeutic Application Type, Through 2027
Table 5: Global Market for Coronary Stents, Through 2027
Table 6: Global Market for Peripheral Vascular Stents, by Therapeutic Application Type, Through 2027
Table 7: Global Market for Peripheral Lower Extremity Stents, by Therapeutic Application Type, Through 2027
Table 8: Global Market for Nonvascular Stents, by Therapeutic Application Type, Through 2027
Table 9: Advantages and Disadvantages of Common Materials Used in Stents
Table 10: Examples of BMS, by Stent Material Type
Table 11: Drugs Commonly used in DES
Table 12: Common Polymers Used in DES
Table 13: Polymer-Based DES and Their Composition
Table 14: Polymer-Free DES and Their Composition
Table 15: Properties of Biodegradable Materials Commonly Used in Biodegradable Stents
Table 16: Commercially Available BDS
Table 17: Selected BDS in Clinical Trials
Table 18: Covered Stents and Their Characteristics
Table 19: Plastic, Hybrid Material, and Silicone Ureteral Stents and Their Characteristics
Table 20: Plastic Biliary and Pancreatic Stents and Their Characteristics
Table 21: Commercially Available Stent Types, by Indication
Table 22: Global Market for Stents, by Stent Type, Through 2027
Table 23: Global Market for Vascular Stents, by Stent Type, Through 2027
Table 24: Global Market for Coronary Stents, by Stent Type, Through 2027
Table 25: Global Market for Peripheral Vascular Stents, by Stent Type, Through 2027
Table 26: Global Market for Nonvascular Stents, by Stent Type, Through 2027
Table 27: Global Market for Stents, by Region, Through 2027
Table 28: North American Market for Stents, by Therapeutic Application Type, Through 2027
Table 29: North American Market for Vascular Stents, by Therapeutic Application Type, Through 2027
Table 30: North American Market for Peripheral Vascular Stents, by Therapeutic Application Type, Through 2027
Table 31: North American Market for Nonvascular Stents, by Therapeutic Application Type, Through 2027
Table 32: Demographic and Healthcare Statistics for European Countries, 2020
Table 33: European Market for Stents, by Therapeutic Application Type, Through 2027
Table 34: European Market for Vascular Stents, by Therapeutic Application Type, Through 2027
Table 35: European Market for Peripheral Vascular Stents, by Therapeutic Application Type, Through 2027
Table 36: European Market for Nonvascular Stents, by Therapeutic Application Type, Through 2027
Table 37: Demographic and Healthcare Statistics for Asia-Pacific Countries, 2020
Table 38: Asia-Pacific Market for Stents, by Therapeutic Application Type, Through 2027
Table 39: Asia-Pacific Market for Vascular Stents, by Therapeutic Application Type, Through 2027
Table 40: Asia-Pacific Market for Peripheral Vascular Stents, by Therapeutic Application Type, Through 2027
Table 41: Asia-Pacific Market for Nonvascular Stents, by Therapeutic Application Type, Through 2027
Table 42: RoW Market for Stents, by Therapeutic Application Type, Through 2027
Table 43: RoW Market for Vascular Stents, by Therapeutic Application Type, Through 2027
Table 44: RoW Market for Peripheral Vascular Stents, by Therapeutic Application Type, Through 2027
Table 45: RoW Market for Nonvascular Stents, by Therapeutic Application Type, Through 2027
Table 46: Number and Distribution of Persons Age 60+, by Region, 2019 and 2050
Table 47: Key Stent Manufacturers' Offerings, by Application Types
Table 48: Global Market Rankings of Coronary Stent Manufacturers, 2021
Table 49: Global Market Rankings of Peripheral Vascular Stent Manufacturers, 2021
Table 50: Global Market Rankings of Nonvascular Stent Manufacturers, 2021
Table 51: Recent Developments in the Market for Stents, 2019-2021
Table 52: Abbott: Stent Portfolio
Table 53: B. Braun Melsungen AG: Stent Portfolio
Table 54: BD: Stent Portfolio
Table 55: Biosensors International: Stent Portfolio
Table 56: Biotronik SE & Co. KG: Stent Portfolio
Table 57: Boston Scientific Corp.: Stent Portfolio
Table 58: Cook Medical LLC: Stent Portfolio
Table 59: Cordis: Stent Portfolio
Table 60: Lepu Medical: Stent Portfolio
Table 61: Medtronic: Stent Portfolio
Table 62: Terumo Corp.: Stent Portfolio
Table 63: W.L. Gore: Stent Portfolio
Table 64: Acronyms Used in This Report
List of Figures
Summary Figure A: Global Market for Stents, by Therapeutic Application Type, 2020-2027
Summary Figure B: Global Market for Vascular Stents, by Therapeutic Application Type, 2020-2027
Figure 1: Global Market Shares of Stents, by Therapeutic Application Type, 2021
Figure 2: Active Clinical Trials for Stents, by Condition, as of Apr. 2022
Figure 3: Global Market Shares of Vascular Stents, by Therapeutic Application Type, 2021
Figure 4: Global Market Shares of Peripheral Vascular Stents, by Therapeutic Application Type, 2021q
Figure 5: Global Market Shares of Peripheral Lower Extremity Stents, by Therapeutic Application Type, 2021
Figure 6: Global Market Shares of Nonvascular Stents, by Therapeutic Application Type, 2021
Figure 7: Global Market for Stents, by Stent Type, 2020-2027
Figure 8: Global Market Shares of Stents, by Stent Type, 2021
Figure 9: Global Market Shares of Peripheral Vascular Stents, by Therapeutic Application Type, 2021q
Figure 10: Global Market Shares of Coronary Stents, by Stent Type, 2021
Figure 11: Global Market Shares of Peripheral Vascular Stents, by Stent Type, 2021
Figure 12: Global Market Shares of Nonvascular Stents, by Stent Type, 2021
Figure 13: Global Market for Stents, by Region, 2020-2027
Figure 14: Global Market Shares of Stents, by Region, 2021
Figure 15: North American Market Shares of Stents, by Therapeutic Application Type, 2021
Figure 16: U.S. Elderly (65 Years and Over) Population, 2010-2050
Figure 17: North American Market Shares of Vascular Stents, by Therapeutic Application Type, 2021
Figure 18: North American Market Shares of Peripheral Vascular Stents, by Therapeutic Application Type, 2021
Figure 19: North American Market Shares of Nonvascular Stents, by Therapeutic Application Type, 2021
Figure 20: European Market Shares of Stents, by Therapeutic Application Type, 2021
Figure 21: European Market Shares of Vascular Stents, by Therapeutic Application Type, 2021
Figure 22: European Market Shares of Peripheral Vascular Stents, by Therapeutic Application Type, 2021
Figure 23: European Market Shares of Nonvascular Stents, by Therapeutic Application Type, 2021
Figure 24: Asia-Pacific Market Shares of Stents, by Therapeutic Application Type, 2021
Figure 25: Asia-Pacific Market Shares of Vascular Stents, by Therapeutic Application Type, 2021
Figure 26: Asia-Pacific Market Shares of Peripheral Vascular Stents, by Therapeutic Application Type, 2021
Figure 27: Asia-Pacific Market Shares of Nonvascular Stents, by Therapeutic Application Type, 2021
Figure 28: RoW Market Shares of Stents, by Therapeutic Application Type, 2021
Figure 29: RoW Market Shares of Vascular Stents, by Therapeutic Application Type, 2021
Figure 30: RoW Market Shares of Peripheral Vascular Stents, by Therapeutic Application Type, 2021
Figure 31: RoW Market Shares of Market for Nonvascular Stents, by Therapeutic Application Type, 2021
Figure 32: Global Geriatric Population (Age 65 and Above), 2014-2022
Figure 33: Prevalence of PAD, by Age Group (Years)
Figure 34: Global Mortality Cases, by Top 10 Causes of Death
Figure 35: Global Adult Population with Cardiovascular Conditions, by Region, 2019
Figure 36: Impact of the COVID-19 Pandemic on the Management of Patients with Acute Coronary Syndromes
Figure 37: Abbott: Annual Revenue, 2018-2021
Figure 38: Abbott: Vascular Business Annual Revenue, 2018-2021
Figure 39: Abbott: Revenue Share, by Country, 2021
Figure 40: B. Braun Melsungen AG: Annual Revenue, 2018-2021
Figure 41: B. Braun Melsungen AG: Revenue Share, by Business Division, 2021
Figure 42: B. Braun Melsungen AG: Revenue Share, by Geography, 2021
Figure 43: BD: Annual Revenue, 2018-2021
Figure 44: BD's Peripheral Intervention Business Segment: Annual Revenue, 2019-2021
Figure 45: BD's Peripheral Intervention Business Segment: Revenue Share, by Geography, 2021
Figure 46: Boston Scientific Corp.: Annual Revenue, 2018-2021
Figure 47: Boston Scientific Corp.: Revenue Share, by Business, 2021
Figure 48: Boston Scientific Corp.: Revenue Share, by Region, 2021
Figure 49: Medtronic: Annual Revenue, 2018-2021
Figure 50: Medtronic Coronary & Peripheral Vascular Segment: Annual Revenue, 2019-2021
Figure 51: Medtronic: Revenue Share, by Region, 2021
Figure 52: Terumo Corp.: Annual Revenue, 2018-2021
Figure 53: Terumo Corp.’s Cardiac and Vascular Business Segment: Annual Revenue, 2018-2021
Figure 54: Terumo Corp.: Revenue Share, by Business Division, 2021
Figure 55: Terumo Corp.: Revenue Share, by Region, 2021

Executive Summary

Cardiovascular diseases are the leading cause of death globally of which coronary artery disease is the most common. Stents are a critical therapy option for coronary and peripheral vascular diseases. Stents are mesh-like tubes of thin wire placed via a delivery catheter into the artery or vein to maintain the lumen. Stents work to restore blood flow to vessels of the heart (coronary) and body (peripheral) that are narrowed or blocked. Stents have been used to treat coronary artery disease (CAD) for more than a decade. Initially limited to use in vascular systems, stents use later expanded to nonvascular systems such as urinary tracts, biliary tracts, pancreatic ducts, gastrointestinal tracts, etc.

From bare-metal stents (BMS) in the 1980s and drug-eluting stents (DES) in the 2000s, scientific innovations in stents have come a long way, turning stents into a multibillion-dollar market growing at a steady rate. Some of the factors contributing to the growth in the stents market include an increasing trend in performing minimally invasive procedures, a rise in the number of cardiovascular and peripheral diseases and the emergence of new products with proven clinical efficiency and efficacy. Moreover, the number of stents used per procedure is increasing as more complex vascular artery disease cases are treated through stenting. Market participants are focusing on product developments to enhance the patient experience, maximize product performance, efficiency, and indications to increase sales/revenue. These product launches have expanded the addressable treatment population and helped to develop greater acceptance of stents as an alternative treatment option for complex arterial diseases, pushing the market forward.

Intense pricing pressures due to growing competition, a changing regulatory landscape and the availability of alternative treatments, coupled with a rise in research and development for those treatments, are some factors limiting or challenging market growth. The market is experiencing continuous price erosion in some product segments such as DES.

The global stents market is growing at a slow to moderate rate, with different devices on different swings. The peripheral vascular stents are on an upswing and are expected to see a high growth rate worldwide. U.S., Europe, and Japan are among the largest regions in terms of stents market share. These markets are reaching a point of saturation, where opportunity is focusing not on market penetration but rather on the opportunity to replace or shift to the newest generation of stents technology.

Companies Mentioned

  • Abbott Laboratories
  • B. Braun Melsungen Ag
  • Becton, Dickinson and Co.
  • Biosensors International
  • Biotronik Se & Co. Kg
  • Boston Scientific Corp.
  • Cook Medical Llc
  • Cordis Corp.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic Plc
  • Terumo Corp.
  • W. L. Gore & Associates, Inc.